Goldman Sachs: GLP-1 Drugs Could Add 1%+ to GDP, Reshape Food Industry
Wall Street bets GLP-1 drugs will transform food. Packaged-food giants are down 50%+ from peaks. Goldman projects these drugs could add over 1% to GDP if adoption reaches 60 million Americans by 2028.